Quality of Life in Prostate Cancer Patients

Recording cancer data in cancer registries is essential for producing reliable population-based data for service planning, monitoring and evaluation. Prostate cancer (PCa) remains the most frequent type of cancer in terms of incidence and mortality in men in the Caribbean. The quality of life PCa cohort will assess quality of life and patient outcomes in Martinique using a digital platform for patient-reported outcome measures.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

CHU de Martinique

Fort-de-France, Martinique

About this study

The Martinique Cancer Registry database is the largest clinical database among the French population-based cancer registries in the Caribbean, including more than 38 000 cancer cases, with 1650 new cancer cases per year, including 550 new PCa cases per year (2010-2014 latest period). In 2020, follow-up will include vital status, assessment of quality of life with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ) Core 30 and the Prostate cancer module QLQ-PR25. Urinary incontinence and erectile dysfunction recorded prior to treatment will be analysed 1, 3 and 5 years after treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age>18 years and residing in Martinique, with prostate cancer diagnosed from 2020
The patient has provided informed consent
Patient with social security coverage

Exclusion criteria

Refusal to participate
Patient with a second cancer, five years after diagnosis
Patient who could not answer the quality of life questionnaires
Patient not fluent in French
Person under legal protection

Treatment and study plan

Primary outcomes

Evaluation of overall Quality of Life: Questionnaire

Time frame: At the date of diagnosis of the disease, at 1 year, 3 years and 5 years

Change of quality of life questionnaire related to sexual dysfunction
Evaluation of overall Quality of Life: Questionnaire

Time frame: At the date of diagnosis of the disease, at 1 year, 3 years and 5 years

Change of quality of life questionnaire related to urinary troubles

Sponsors and collaborators

Lead sponsor

University Hospital Center of Martinique

Other

Collaborators

European Regional Development Fund

Registry information

Official study title

Quality of Life in Prostate Cancer Patients: Challenges and Prospects for Reducing Disparities in the Caribbean

Acronym: QoLProstateMQ

Important dates

Study start: 2020
Primary completion: 2027
Study completion: 2028
First posted: Apr 22, 2020
Registry last updated: Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting